209 related articles for article (PubMed ID: 18288089)
41. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
Bagosi Z; Palotai M; Simon B; Bokor P; Buzás A; Balangó B; Pintér D; Jászberényi M; Csabafi K; Szabó G
Brain Res; 2016 Dec; 1652():21-29. PubMed ID: 27693397
[TBL] [Abstract][Full Text] [Related]
42. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
[TBL] [Abstract][Full Text] [Related]
43. The CRF
Piccin A; Contarino A
J Neurosci Res; 2022 Jan; 100(1):309-321. PubMed ID: 32725663
[TBL] [Abstract][Full Text] [Related]
44. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats.
Pan Y; Wang FM; Qiang LQ; Zhang DM; Kong LD
Psychoneuroendocrinology; 2010 Feb; 35(2):272-83. PubMed ID: 19631474
[TBL] [Abstract][Full Text] [Related]
45. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
[TBL] [Abstract][Full Text] [Related]
46. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
[TBL] [Abstract][Full Text] [Related]
47. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
[TBL] [Abstract][Full Text] [Related]
48. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
49. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
Eisenberg RM
J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
[TBL] [Abstract][Full Text] [Related]
50. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
[TBL] [Abstract][Full Text] [Related]
51. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.
Skelton KH; Gutman DA; Thrivikraman KV; Nemeroff CB; Owens MJ
Psychopharmacology (Berl); 2007 Jun; 192(3):385-96. PubMed ID: 17297634
[TBL] [Abstract][Full Text] [Related]
52. Central administration of aminoprocalcitonin inhibits food intake and stimulates the hypothalamic-pituitary-adrenal axis in rats via the corticotrophin-releasing factor system.
Tavares E; Maldonado R; Garcia-Martinez A; Miñano FJ
J Neuroendocrinol; 2012 Jul; 24(7):1040-54. PubMed ID: 22372932
[TBL] [Abstract][Full Text] [Related]
53. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
McNally GP; Akil H
Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
[TBL] [Abstract][Full Text] [Related]
54. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
[TBL] [Abstract][Full Text] [Related]
55. CRF₂ receptor-deficiency reduces recognition memory deficits and vulnerability to stress induced by cocaine withdrawal.
Morisot N; Le Moine C; Millan MJ; Contarino A
Int J Neuropsychopharmacol; 2014 Dec; 17(12):1969-79. PubMed ID: 24800964
[TBL] [Abstract][Full Text] [Related]
56. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
57. Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression.
Skelton KH; Nemeroff CB; Owens MJ
J Neurosci; 2004 Oct; 24(42):9303-12. PubMed ID: 15496666
[TBL] [Abstract][Full Text] [Related]
58. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
59. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
60. Corticosterone-induced negative feedback mechanisms within the hypothalamo-pituitary-adrenal axis of the chicken.
Vandenborne K; De Groef B; Geelissen SM; Kühn ER; Darras VM; Van der Geyten S
J Endocrinol; 2005 Jun; 185(3):383-91. PubMed ID: 15930164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
